517
Views
6
CrossRef citations to date
0
Altmetric
Original Article

A prospective longitudinal survey of erectile function status in symptomatic benign prostatic hyperplasia patients treated with dutasteride

, , , , , , , & show all
Pages 111-116 | Received 11 Jan 2016, Accepted 16 Feb 2016, Published online: 10 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Marcello H. A. Da Silva, Jorge L. Medeiros$suffix/text()$suffix/text(), Waldemar S. Costa, Francisco J. B. Sampaio & Diogo B. De Souza. (2020) Effects of the dutasteride and sildenafil association in the penis of a benign prostatic hyperplasia animal model. The Aging Male 23:5, pages 1009-1015.
Read now
Julian Soans, Mahmood Vazirian-Zadeh, Francesca Kum, Randeep Dhariwal, Mohamed Omran Breish, Sohail Singh, Wasim Mahmalji & Samer Katmawi-Sabbagh. (2020) Can surgical treatment for benign prostatic hyperplasia improve sexual function? A systematic review. The Aging Male 23:5, pages 770-779.
Read now
Abdullah Gul, Serdar Altinay, Levent Kabasakal, Abdulmecit Yavuz, Atilla Semercioz & Ege Can Serefoglu. (2020) Effect of tadalafil on penile nitric oxide synthase and corporal smooth muscle in rats under dutasteride treatment. The Aging Male 23:2, pages 161-167.
Read now

Articles from other publishers (2)

Daisuke Gotoh, Kazumasa Torimoto, Yosuke Morizawa, Shunta Hori, Yasushi Nakai, Makito Miyake & Kiyohide Fujimoto. (2022) Efficacy and safety of dutasteride with tadalafil add-on therapy in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia. BMC Research Notes 15:1.
Crossref
Naoki Wada, Noriyuki Abe, Kotona Miyauchi, Mayumi Ishikawa, Shogo Makino & Hidehiro Kakizaki. (2022) Dutasteride add-on treatment to tadalafil for patients with benign prostatic enlargement is similarly effective as dutasteride add-on treatment to alpha blocker: a propensity-score matching analysis. International Urology and Nephrology 54:6, pages 1193-1198.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.